Table 3.
MDR-TB patient characteristics, MDR-TB surveillance programme, Madagascar, 2012–2017
| Presumptive MDR-TB | MDR-TB | Univariable logistic regression | |||
|---|---|---|---|---|---|
| n (%) | n | % (95% CI) | Unadjusted OR (95% CI) | p-value | |
| Total | 2391 (100.0) | 89 | 3.7 (3.0–4.6) | – | – |
| Gender | |||||
| Male | 1620 (68.1) | 60 | 3.7 (2.8–4.7) | 1.00 (reference population) | |
| Female | 760 (31.9) | 29 | 3.8 (2.6–5.4) | 1.06 (0.67–1.67) | 0.802 |
| Median age (in years [range]) | 40 [2–88] | 40 [12–67] | – | – | – |
| Previous treatment history | |||||
| Relapse | 1476 (61.7) | 39 | 2.6 (1.9–3.6) | 1.00 (reference population) | |
| Failure | 333 (13.9) | 33 | 9.9 (6.9–13.6) | 3.87 (2.39–6.28) | < 0.001 |
| Retreatment | 243 (10.2) | 4 | 1.6 (0.5–4.2) | 0.58 (0.21–1.64) | 0.304 |
| Unknown | 339 (14.2) | 13 | 3.8 (2.1–6.5) | 1.70 (0.90–3.24) | 0.104 |
CI confidence interval, MDR-TB multidrug-resistant tuberculosis, OR odds ratio